Dohyun Im
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dohyun Im has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- So Iwata
Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
8 shared publications - Eriko Nango
Graduate School of Science Tohoku University Sendai Miyagi Japan
4 shared publications - Hidetsugu Asada
Kyoto University
4 shared publications - Takayuki Kato
Institute for Protein Research, The University of Osaka, Suita, Osaka, Japan
4 shared publications - Alena Ramanishka
Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, USA
3 shared publications - Eduard Fron
Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Heverlee, Belgium
3 shared publications
Latest Publications
- Open Access
- 25 June 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Direct visualization of hydroperoxy intermediate in fluorescent protein chromophore maturation in PAmCherry1
Despite the widespread use of fluorescent proteins in bioimaging, the mechanism of oxidative chromophore maturation to form the tyrosine C ???? =C ???? double bond remains unclear. In the photoactivatable fluorescent protein PAmCherry1, this double bond has not yet been formed prior to photoactivation. Here, serial femtosecond crystallography (SFX) using an X-ray free electron laser (XFEL) enabled us to capture the radiation damage-free structure of non-photoactivated PAmCherry1. This structure displayed a covalently bound hydroperoxy moiety (73% occupancy) at the sp 3 -hybridized C ???? atom of the chromophore tyrosine residue within the imidazolinone ring. Unique hydrogen-bonding networks surrounding the hydroperoxy moiety stabilize this highly reactive chromophore species. Electrospray ionization mass spectrometry (ESI-MS) supported the coexistence of hydroperoxy and enolate chromophore forms. According to spectroscopic analysis, these species exist in dynamic equilibrium. MS analysis further demonstrated that photoactivation is accompanied by the formation of the mature chromophore containing a C ???? =C ???? double bond together with Kolbe decarboxylation. Time-resolved SFX (TR-SFX) using a femtosecond pump laser further revealed decreasing electron density at 800 ps after photoexcitation, consistent with rapid oxidation and decarboxylation. Collectively, these results support a hydroperoxy intermediate as a key species in oxidative chromophore maturation, which is stabilized in non-photoactivated PAmCherry1.
- 25 June 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDirect visualization of hydroperoxy intermediate in fluorescent protein chromophore maturation in PAmCherry1
Despite the widespread use of fluorescent proteins in bioimaging, the mechanism of oxidative chromophore maturation to form the tyrosine C ???? =C ???? double bond remains unclear. In the photoactivatable fluorescent protein PAmCherry1, this double bond has not yet been formed prior to photoactivation. Here, serial femtosecond crystallography (SFX) using an X-ray free electron laser (XFEL) enabled us to capture the radiation damage-free structure of non-photoactivated PAmCherry1. This structure displayed a covalently bound hydroperoxy moiety (73% occupancy) at the sp 3 -hybridized C ???? atom of the chromophore tyrosine residue within the imidazolinone ring. Unique hydrogen-bonding networks surrounding the hydroperoxy moiety stabilize this highly reactive chromophore species. Electrospray ionization mass spectrometry (ESI-MS) supported the coexistence of hydroperoxy and enolate chromophore forms. According to spectroscopic analysis, these species exist in dynamic equilibrium. MS analysis further demonstrated that photoactivation is accompanied by the formation of the mature chromophore containing a C ???? =C ???? double bond together with Kolbe decarboxylation. Time-resolved SFX (TR-SFX) using a femtosecond pump laser further revealed decreasing electron density at 800 ps after photoexcitation, consistent with rapid oxidation and decarboxylation. Collectively, these results support a hydroperoxy intermediate as a key species in oxidative chromophore maturation, which is stabilized in non-photoactivated PAmCherry1.
- Open Access
- 12 April 2026
- Published by American Chemical Society (ACS) in ACS Physical Chemistry Au
- Vol. 6 (3) , 534-551
Decarboxylation via a Higher Electronic Excited State Drives LSSmOrange Photoconversion
LSSmOrange is a fluorescent protein that exhibits slow photoconversion and is used as an imaging tool to highlight specific subpopulations of molecules. While photoconversion in LSSmOrange is known to involve Kolbe decarboxylation of the E215 side chain, its structural dynamics remain unexplored. We addressed the excited state dynamics of LSSmOrange by using serial femtosecond crystallography (SFX) with an X-ray free electron laser. SFX enabled us to determine the crystal structure of unconverted LSSmOrange without detectable X-ray damage, facilitating a femtosecond optical pump─X-ray probe experiment to track time-resolved structural changes. A decrease in electron density at E215 was observed 250 ps after strong pump laser illumination (mean fluence of 0.31 J/cm2), consistent with photoconversion by decarboxylation. Extrapolated structures suggested the appearance of an alternative E215 conformation in addition to illumination-induced decarboxylation. Since the photoinduced decarboxylation occurred despite the extremely low single-photon photoconversion quantum yield of LSSmOrange (8.5 × 10–6), we hypothesized that the photoconversion proceeds via a multiphoton process. Power titration using transient absorption spectroscopy revealed that photoconversion was linked to optical nonlinearity under a high pump laser energy. We propose that LSSmOrange photoconversion involves a higher-lying electronic excited state triggered by multiphoton absorption, as supported by quantum-chemical calculations. Photoconversion via a multiphoton process enables spatially confined highlighting on a microscope.
- 12 April 2026
- Published by American Chemical Society (ACS) in ACS Physical Chemistry Au
- Vol. 6 (3) , 534-551
Open AccessDecarboxylation via a Higher Electronic Excited State Drives LSSmOrange Photoconversion
LSSmOrange is a fluorescent protein that exhibits slow photoconversion and is used as an imaging tool to highlight specific subpopulations of molecules. While photoconversion in LSSmOrange is known to involve Kolbe decarboxylation of the E215 side chain, its structural dynamics remain unexplored. We addressed the excited state dynamics of LSSmOrange by using serial femtosecond crystallography (SFX) with an X-ray free electron laser. SFX enabled us to determine the crystal structure of unconverted LSSmOrange without detectable X-ray damage, facilitating a femtosecond optical pump─X-ray probe experiment to track time-resolved structural changes. A decrease in electron density at E215 was observed 250 ps after strong pump laser illumination (mean fluence of 0.31 J/cm2), consistent with photoconversion by decarboxylation. Extrapolated structures suggested the appearance of an alternative E215 conformation in addition to illumination-induced decarboxylation. Since the photoinduced decarboxylation occurred despite the extremely low single-photon photoconversion quantum yield of LSSmOrange (8.5 × 10–6), we hypothesized that the photoconversion proceeds via a multiphoton process. Power titration using transient absorption spectroscopy revealed that photoconversion was linked to optical nonlinearity under a high pump laser energy. We propose that LSSmOrange photoconversion involves a higher-lying electronic excited state triggered by multiphoton absorption, as supported by quantum-chemical calculations. Photoconversion via a multiphoton process enables spatially confined highlighting on a microscope.
- Open Access
- 22 January 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Decarboxylation via a higher electronic excited state drives LSSmOrange photoconversion
LSSmOrange is a fluorescent protein that exhibits slow photoconversion and is used as an imaging tool to highlight specific subpopulations of molecules. While photoconversion in LSSmOrange is known to involve Kolbe decarboxylation of the E215 side chain, its structural dynamics remain unexplored. We addressed the excited state dynamics of LSSmOrange using serial femtosecond crystallography (SFX) with an X-ray free electron laser (XFEL). SFX enabled us to determine the crystal structure of unconverted LSSmOrange without detectable X-ray damage, facilitating a femtosecond optical pump-X-ray probe experiment to track time-resolved structural changes. A decrease in electron density at E215 was observed 250 ps after strong pump laser illumination (mean fluence of 0.31 J/cm 2 ), consistent with photoconversion by decarboxylation. Extrapolated structures suggested the appearance of an alternative E215 conformation in addition to the illumination-induced decarboxylation. Since the photoinduced decarboxylation occurred despite the extremely low single-photon photoconversion quantum yield of LSSmOrange (8.5 x 10 -6 ), we hypothesized that the photoconversion proceeds via a multiphoton process. Power titration using transient absorption spectroscopy revealed that photoconversion was linked to optical nonlinearity under high pump laser energy. We propose that LSSmOrange photoconversion involves a higher-lying electronic excited state triggered by multiphoton absorption, as supported by quantumchemical calculations. Photoconversion via a multiphoton process enables spatially confined highlighting on a microscope.
- 22 January 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDecarboxylation via a higher electronic excited state drives LSSmOrange photoconversion
LSSmOrange is a fluorescent protein that exhibits slow photoconversion and is used as an imaging tool to highlight specific subpopulations of molecules. While photoconversion in LSSmOrange is known to involve Kolbe decarboxylation of the E215 side chain, its structural dynamics remain unexplored. We addressed the excited state dynamics of LSSmOrange using serial femtosecond crystallography (SFX) with an X-ray free electron laser (XFEL). SFX enabled us to determine the crystal structure of unconverted LSSmOrange without detectable X-ray damage, facilitating a femtosecond optical pump-X-ray probe experiment to track time-resolved structural changes. A decrease in electron density at E215 was observed 250 ps after strong pump laser illumination (mean fluence of 0.31 J/cm 2 ), consistent with photoconversion by decarboxylation. Extrapolated structures suggested the appearance of an alternative E215 conformation in addition to the illumination-induced decarboxylation. Since the photoinduced decarboxylation occurred despite the extremely low single-photon photoconversion quantum yield of LSSmOrange (8.5 x 10 -6 ), we hypothesized that the photoconversion proceeds via a multiphoton process. Power titration using transient absorption spectroscopy revealed that photoconversion was linked to optical nonlinearity under high pump laser energy. We propose that LSSmOrange photoconversion involves a higher-lying electronic excited state triggered by multiphoton absorption, as supported by quantumchemical calculations. Photoconversion via a multiphoton process enables spatially confined highlighting on a microscope.
- Open Access
- 8 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Structural basis for the subtype-selectivity of KCa2.2 channel activators
Small-conductance (KCa2.2) and intermediate-conductance (KCa3.1) Ca2+-activated K+ channels are gated by a Ca2+-calmodulin dependent mechanism. NS309 potentiates the activity of both KCa2.2 and KCa3.1, while rimtuzalcap selectively activates KCa2.2. Rimtuzalcap has been used in clinical trials for the treatment of spinocerebellar ataxia and essential tremor. We report cryo-electron microscopy structures of NS309-bound KCa2.2 and KCa3.1, in addition to structures of rimtuzalcap-bound KCa2.2 and mutant KCa3.1_R355K. The different conformations of calmodulin and the cytoplasmic HC helices in the two channels underlie the subtype-selectivity of rimtuzalcap for KCa2.2. NS309 binds to pre-existing pockets in both channels, while the bulkier rimtuzalcap binds in an induced-fit pocket in KCa2.2 requiring conformational changes. In KCa2.2, calmodulin’s N-lobes are sufficiently far apart to enable conformational changes to accommodate either NS309 or rimtuzalcap. In KCa3.1, calmodulin’s N-lobes are closer to each other and constrained by KCa3.1’s HC helices, which allows binding of NS309 but not rimtuzalcap. Replacement of arginine-355 in KCa3.1’s HB helix with lysine (KCa3.1_R355K) allows the binding of rimtuzalcap and renders the mutant channel sensitive to rimtuzalcap. These structures provide a framework for structure-based drug design targeting KCa2.2 channels.
- 8 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessStructural basis for the subtype-selectivity of KCa2.2 channel activators
Small-conductance (KCa2.2) and intermediate-conductance (KCa3.1) Ca2+-activated K+ channels are gated by a Ca2+-calmodulin dependent mechanism. NS309 potentiates the activity of both KCa2.2 and KCa3.1, while rimtuzalcap selectively activates KCa2.2. Rimtuzalcap has been used in clinical trials for the treatment of spinocerebellar ataxia and essential tremor. We report cryo-electron microscopy structures of NS309-bound KCa2.2 and KCa3.1, in addition to structures of rimtuzalcap-bound KCa2.2 and mutant KCa3.1_R355K. The different conformations of calmodulin and the cytoplasmic HC helices in the two channels underlie the subtype-selectivity of rimtuzalcap for KCa2.2. NS309 binds to pre-existing pockets in both channels, while the bulkier rimtuzalcap binds in an induced-fit pocket in KCa2.2 requiring conformational changes. In KCa2.2, calmodulin’s N-lobes are sufficiently far apart to enable conformational changes to accommodate either NS309 or rimtuzalcap. In KCa3.1, calmodulin’s N-lobes are closer to each other and constrained by KCa3.1’s HC helices, which allows binding of NS309 but not rimtuzalcap. Replacement of arginine-355 in KCa3.1’s HB helix with lysine (KCa3.1_R355K) allows the binding of rimtuzalcap and renders the mutant channel sensitive to rimtuzalcap. These structures provide a framework for structure-based drug design targeting KCa2.2 channels.
- Open Access
- 18 November 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (47)
Structural insights into the G-protein subtype selectivity revealed by human sphingosine-1-phosphate receptor 3–G q complexes
Sphingosine-1-phosphate (S1P) is one of the most extensively studied bioactive lipids that transduces signals via the S1P receptor (S1PR) family (S1PR1-5), a class of G-protein-coupled receptors (GPCRs), to regulate immune cell migration, vascular permeability, and pain modulation. However, the mechanism for achieving specificity in downstream signaling remains poorly understood. Here, we present cryogenic electron microscopic structures of the S1PR3-G αq complex bound to endogenous agonists: d18:1 S1P or d16:1 S1P. Both agonists shared the same binding pocket and binding mode despite the different signaling intensities of the S1PR3-G αq signal pathway. By comparing the structures of two agonist-bound complexes, combined with mutagenesis studies, we identified key amino acids, Phe119 3.33 and Arg136 3.50 , that play crucial roles in differential agonist recognition and receptor activation. Furthermore, structural comparisons with previously determined S1PR3-G αi complex or G-protein-free S1PR3 structures, along with mutagenesis analysis, revealed dynamic intracellular loop 2 conformations and specific amino acid interactions that contribute to G-protein selectivity. Notably, we identified amino acids at the 34.50 and 34.53 positions within ICL2 as critical for specific interactions with G proteins. These findings provide better understanding of the mechanism of GPCR activation and unique perspectives that can be applied to other class A GPCRs, leading to the possibility of optimized drug development.
- 18 November 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (47)
Open AccessStructural insights into the G-protein subtype selectivity revealed by human sphingosine-1-phosphate receptor 3–G q complexes
Sphingosine-1-phosphate (S1P) is one of the most extensively studied bioactive lipids that transduces signals via the S1P receptor (S1PR) family (S1PR1-5), a class of G-protein-coupled receptors (GPCRs), to regulate immune cell migration, vascular permeability, and pain modulation. However, the mechanism for achieving specificity in downstream signaling remains poorly understood. Here, we present cryogenic electron microscopic structures of the S1PR3-G αq complex bound to endogenous agonists: d18:1 S1P or d16:1 S1P. Both agonists shared the same binding pocket and binding mode despite the different signaling intensities of the S1PR3-G αq signal pathway. By comparing the structures of two agonist-bound complexes, combined with mutagenesis studies, we identified key amino acids, Phe119 3.33 and Arg136 3.50 , that play crucial roles in differential agonist recognition and receptor activation. Furthermore, structural comparisons with previously determined S1PR3-G αi complex or G-protein-free S1PR3 structures, along with mutagenesis analysis, revealed dynamic intracellular loop 2 conformations and specific amino acid interactions that contribute to G-protein selectivity. Notably, we identified amino acids at the 34.50 and 34.53 positions within ICL2 as critical for specific interactions with G proteins. These findings provide better understanding of the mechanism of GPCR activation and unique perspectives that can be applied to other class A GPCRs, leading to the possibility of optimized drug development.
- Open Access
- 16 May 2025
- Published by Springer Nature in Research Square
Structural basis for the subtype-selectivity of KCa2.2 channel activators
Small-conductance (K Ca 2.2) and intermediate-conductance (K Ca 3.1) Ca 2+ -activated K + channels are gated by a Ca 2+ -calmodulin dependent mechanism. NS309 potentiates the activity of both K Ca 2.2 and K Ca 3.1, while rimtuzalcap selectively activates K Ca 2.2. Rimtuzalcap has been used in clinical trials for the treatment of spinocerebellar ataxia and essential tremor. We report cryo-electron microscopy structures of K Ca 2.2 channels bound with NS309 and rimtuzalcap, in addition to K Ca 3.1 channels with NS309. The different conformations of calmodulin and the cytoplasmic HC helices in the two channels underlie the subtype-selectivity of rimtuzalcap for K Ca 2.2. Calmodulin’s N-lobes in the K Ca 2.2 structure are far apart and undergo conformational changes to accommodate either NS309 or rimtuzalcap. Calmodulin’s N-lobes in the K Ca 3.1 structure are closer to each other and are constrained by the HC helices of K Ca 3.1, which allows binding of NS309 but not of the bulkier rimtuzalcap. These structures provide a framework for structure-based drug design targeting K Ca 2.2 channels.
- 16 May 2025
- Published by Springer Nature in Research Square
Open AccessStructural basis for the subtype-selectivity of KCa2.2 channel activators
Small-conductance (K Ca 2.2) and intermediate-conductance (K Ca 3.1) Ca 2+ -activated K + channels are gated by a Ca 2+ -calmodulin dependent mechanism. NS309 potentiates the activity of both K Ca 2.2 and K Ca 3.1, while rimtuzalcap selectively activates K Ca 2.2. Rimtuzalcap has been used in clinical trials for the treatment of spinocerebellar ataxia and essential tremor. We report cryo-electron microscopy structures of K Ca 2.2 channels bound with NS309 and rimtuzalcap, in addition to K Ca 3.1 channels with NS309. The different conformations of calmodulin and the cytoplasmic HC helices in the two channels underlie the subtype-selectivity of rimtuzalcap for K Ca 2.2. Calmodulin’s N-lobes in the K Ca 2.2 structure are far apart and undergo conformational changes to accommodate either NS309 or rimtuzalcap. Calmodulin’s N-lobes in the K Ca 3.1 structure are closer to each other and are constrained by the HC helices of K Ca 3.1, which allows binding of NS309 but not of the bulkier rimtuzalcap. These structures provide a framework for structure-based drug design targeting K Ca 2.2 channels.
- Open Access
- 17 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Cryo-EM structures of the small-conductance Ca2+-activated KCa2.2 channel
Small-conductance Ca2+-activated K+ (KCa2.1-KCa2.3) channels modulate neuronal and cardiac excitability. We report cryo-electron microscopy structures of the KCa2.2 channel in complex with calmodulin and Ca2+, alone or bound to two small molecule inhibitors, at 3.18, 3.50, 2.99 and 2.97 angstrom resolution, respectively. Extracellular S3-S4 loops in β-hairpin configuration form an outer canopy over the pore with an aromatic box at the canopy’s center. Each S3-S4 β-hairpin is tethered to the selectivity filter in the neighboring subunit by inter-subunit hydrogen bonds. This hydrogen bond network flips the aromatic residue (Tyr362) in the filter’s GYG signature by 180°, causing the outer selectivity filter to widen and water to enter the filter. Disruption of the tether by a mutation narrows the outer selectivity filter, realigns Tyr362 to the position seen in other K+ channels, and significantly increases unitary conductance. UCL1684, a mimetic of the bee venom peptide apamin, sits atop the canopy and occludes the opening in the aromatic box. AP14145, an analogue of a therapeutic for atrial fibrillation, binds in the central cavity below the selectivity filter and induces closure of the inner gate. These structures provide a basis for understanding the small unitary conductance and pharmacology of KCa2.x channels.
- 17 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessCryo-EM structures of the small-conductance Ca2+-activated KCa2.2 channel
Small-conductance Ca2+-activated K+ (KCa2.1-KCa2.3) channels modulate neuronal and cardiac excitability. We report cryo-electron microscopy structures of the KCa2.2 channel in complex with calmodulin and Ca2+, alone or bound to two small molecule inhibitors, at 3.18, 3.50, 2.99 and 2.97 angstrom resolution, respectively. Extracellular S3-S4 loops in β-hairpin configuration form an outer canopy over the pore with an aromatic box at the canopy’s center. Each S3-S4 β-hairpin is tethered to the selectivity filter in the neighboring subunit by inter-subunit hydrogen bonds. This hydrogen bond network flips the aromatic residue (Tyr362) in the filter’s GYG signature by 180°, causing the outer selectivity filter to widen and water to enter the filter. Disruption of the tether by a mutation narrows the outer selectivity filter, realigns Tyr362 to the position seen in other K+ channels, and significantly increases unitary conductance. UCL1684, a mimetic of the bee venom peptide apamin, sits atop the canopy and occludes the opening in the aromatic box. AP14145, an analogue of a therapeutic for atrial fibrillation, binds in the central cavity below the selectivity filter and induces closure of the inner gate. These structures provide a basis for understanding the small unitary conductance and pharmacology of KCa2.x channels.
- 20 January 2025
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 32 (3) , 531-542
The structure and function of the ghrelin receptor coding for drug actions
Drugs targeting the ghrelin receptor hold therapeutic potential in anorexia, obesity and diabetes. However, developing effective drugs is challenging. To tackle this common issue across a broad drug target, this study aims to understand how anamorelin, the only approved drug targeting the ghrelin receptor, operates compared to other synthetic drugs. Our research elucidated the receptor’s structure with anamorelin and miniGq, unveiling anamorelin’s superagonistic activity. We demonstrated that ligands with distinct chemical structures uniquely bind to the receptor, resulting in diverse conformations and biasing signal transduction. Moreover, our study showcased the utility of structural information in effectively identifying natural genetic variations altering drug action and causing severe functional deficiencies, offering a basis for selecting the right medication on the basis of the individual’s genomic sequence. Thus, by building on structural analysis, this study enhances the foundational framework for selecting therapeutic agents targeting the ghrelin receptor, by effectively leveraging signaling bias and genetic variations.
- 20 January 2025
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 32 (3) , 531-542
The structure and function of the ghrelin receptor coding for drug actions
Drugs targeting the ghrelin receptor hold therapeutic potential in anorexia, obesity and diabetes. However, developing effective drugs is challenging. To tackle this common issue across a broad drug target, this study aims to understand how anamorelin, the only approved drug targeting the ghrelin receptor, operates compared to other synthetic drugs. Our research elucidated the receptor’s structure with anamorelin and miniGq, unveiling anamorelin’s superagonistic activity. We demonstrated that ligands with distinct chemical structures uniquely bind to the receptor, resulting in diverse conformations and biasing signal transduction. Moreover, our study showcased the utility of structural information in effectively identifying natural genetic variations altering drug action and causing severe functional deficiencies, offering a basis for selecting the right medication on the basis of the individual’s genomic sequence. Thus, by building on structural analysis, this study enhances the foundational framework for selecting therapeutic agents targeting the ghrelin receptor, by effectively leveraging signaling bias and genetic variations.
- Open Access
- 16 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-10
Neurotransmitter recognition by human vesicular monoamine transporter 2
Human vesicular monoamine transporter 2 (VMAT2), a member of the SLC18 family, plays a crucial role in regulating neurotransmitters in the brain by facilitating their uptake and storage within vesicles, preparing them for exocytotic release. Because of its central role in neurotransmitter signalling and neuroprotection, VMAT2 is a target for neurodegenerative diseases and movement disorders, with its inhibitor being used as therapeutics. Despite the importance of VMAT2 in pharmacophysiology, the molecular basis of VMAT2-mediated neurotransmitter transport and its inhibition remains unclear. Here we show the cryo-electron microscopy structure of VMAT2 in the substrate-free state, in complex with the neurotransmitter dopamine, and in complex with the inhibitor tetrabenazine. In addition to these structural determinations, monoamine uptake assays, mutational studies, and pKa value predictions were performed to characterize the dynamic changes in VMAT2 structure. These results provide a structural basis for understanding VMAT2-mediated vesicular transport of neurotransmitters and a platform for modulation of current inhibitor design.
- 16 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-10
Open AccessNeurotransmitter recognition by human vesicular monoamine transporter 2
Human vesicular monoamine transporter 2 (VMAT2), a member of the SLC18 family, plays a crucial role in regulating neurotransmitters in the brain by facilitating their uptake and storage within vesicles, preparing them for exocytotic release. Because of its central role in neurotransmitter signalling and neuroprotection, VMAT2 is a target for neurodegenerative diseases and movement disorders, with its inhibitor being used as therapeutics. Despite the importance of VMAT2 in pharmacophysiology, the molecular basis of VMAT2-mediated neurotransmitter transport and its inhibition remains unclear. Here we show the cryo-electron microscopy structure of VMAT2 in the substrate-free state, in complex with the neurotransmitter dopamine, and in complex with the inhibitor tetrabenazine. In addition to these structural determinations, monoamine uptake assays, mutational studies, and pKa value predictions were performed to characterize the dynamic changes in VMAT2 structure. These results provide a structural basis for understanding VMAT2-mediated vesicular transport of neurotransmitters and a platform for modulation of current inhibitor design.
- Open Access
- 20 December 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 695, 149393
Crystal structure reveals the binding mode and selectivity of a photoswitchable ligand for the adenosine A2A receptor
- 20 December 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 695, 149393
Open AccessCrystal structure reveals the binding mode and selectivity of a photoswitchable ligand for the adenosine A2A receptor